PEAK6 Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
PEAK6 Investments's GILD Position: Q4 2023 in Review
PEAK6 Investments sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 3,478 shares — an estimated $271K sold.
PEAK6 Investments first reported a position in GILD in Q3 2018 and held it in 19 quarters. The position peaked at $18.8M in Q4 2018. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.
- PEAK6 Investments reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
- PEAK6 Investments sold 3,478 Gilead Sciences shares in Q4 2023, an estimated $271K.
- PEAK6 Investments first reported a position in Gilead Sciences in Q3 2018 and held it in 19 quarters.
- PEAK6 Investments's Gilead Sciences position peaked at $18.8M in Q4 2018.
- 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.
Based on PEAK6 Investments's 13F filing for Q4 2023, filed 13 Feb 2024.